Clinical trial
Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis
NCT01239719 is registered in ClinicalTrials.gov with Azidus Brasil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Study for Effectiveness and Safety Evaluation of Dexamethasone 0.5 mg + Fumarate Clemastine 1 mg Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis
- Lead sponsor
- Azidus Brasil
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- March 31, 2011
- Completion date
- December 31, 2011
- Enrollment
- 96 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
allergy, dermatitis